Abstract
1 The elimination of antipyrine from saliva was measured in six children aged 5 months to 5 years during fever and during a control period 2-4 weeks after the cessation of fever. 2 The mean (+/- s.d.) saliva antipyrine clearance during fever, 32 +/- 13 ml kg-1 h-1, was nearly 50% less than that when the children were afebrile, 50 +/- 22 ml kg-1 h-1 (P less than 0.02). The mean saliva antipyrine half-life during fever, 15.20 +/- 5.40 h, was almost twice as long as that found when body temperature was normal, 9.18 +/- 2.49 h (P less than 0.01). The apparent volume of distribution of antipyrine was not significantly affected by fever. 3 These findings indicate that drug metabolising ability in children is impaired during fever.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alvares A. P., Kapelner S., Sassa S., Kappas A. Drug metabolism in normal children, lead-poisoned children, and normal adults. Clin Pharmacol Ther. 1975 Feb;17(2):179–183. doi: 10.1002/cpt1975172179. [DOI] [PubMed] [Google Scholar]
- Atkins E., Bodel P. Fever. N Engl J Med. 1972 Jan 6;286(1):27–34. doi: 10.1056/NEJM197201062860109. [DOI] [PubMed] [Google Scholar]
- Bacon C. J., Mucklow J. C., Saunders A., Rawlins M. D., Webb J. K. A method for obtaining saliva samples from infants and young children. Br J Clin Pharmacol. 1978 Jan;5(1):89–90. doi: 10.1111/j.1365-2125.1978.tb01604.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Branch R. A., Shand D. G., Wilkinson G. R., Nies A. S. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. J Clin Invest. 1974 Apr;53(4):1101–1107. doi: 10.1172/JCI107647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breckenridge A., Orme M. L., Thorgeirsson S., Davies D. S., Brooks R. V. Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine). Clin Sci. 1971 Apr;40(4):351–364. doi: 10.1042/cs0400351. [DOI] [PubMed] [Google Scholar]
- Elin R. J., Vesell E. S., Wolff S. M. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance. Clin Pharmacol Ther. 1975 Apr;17(4):447–457. doi: 10.1002/cpt1975174447. [DOI] [PubMed] [Google Scholar]
- Park B. K., Breckenridge A. M. Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokinet. 1981 Jan-Feb;6(1):1–24. doi: 10.2165/00003088-198106010-00001. [DOI] [PubMed] [Google Scholar]
- Saenger P., Rifkind A. B., New M. I. Changes in drug metabolism in children with thyroid disorders. J Clin Endocrinol Metab. 1976 Jan;42(1):155–159. doi: 10.1210/jcem-42-1-155. [DOI] [PubMed] [Google Scholar]
- Shand D. G., Evans G. H., Nies A. S. The almost complete hepatic extraction of propranolol during intravenous administration in the dog. Life Sci I. 1971 Dec 15;10(24):1417–1421. doi: 10.1016/0024-3205(71)90271-2. [DOI] [PubMed] [Google Scholar]
- Stevenson I. H. Factors influencing antipyrine elimination. Br J Clin Pharmacol. 1977 Jun;4(3):261–265. doi: 10.1111/j.1365-2125.1977.tb00710.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sultatos L. G., Dvorchik B. H., Vesell E. S., Shand D. G., Branch R. A. Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine. Clin Pharmacokinet. 1980 May-Jun;5(3):263–273. doi: 10.2165/00003088-198005030-00005. [DOI] [PubMed] [Google Scholar]
- Trenholme G. M., Williams R. L., Rieckmann K. H., Frischer H., Carson P. E. Quinine disposition during malaria and during induced fever. Clin Pharmacol Ther. 1976 Apr;19(4):459–467. doi: 10.1002/cpt1976194459. [DOI] [PubMed] [Google Scholar]
- Vesell E. S., Page J. G. Genetic control of drug levels in man: antipyrine. Science. 1968 Jul 5;161(3836):72–73. doi: 10.1126/science.161.3836.72. [DOI] [PubMed] [Google Scholar]
- WHITEHOUSE F., Jr, OBENG S. A., PEQUET A. R., CHAMNESS J. K., JENDER J. K., WILSON J. L. SERUM LEVELS OF POTASSIUM PENICILLIN V FOLLOWING ORAL ADMINISTRATION TO FEBRILE AND AFEBRILE CHILDREN. Pediatrics. 1963 Nov;32:919–922. [PubMed] [Google Scholar]